Cytek Biosciences (CTKB) News Today → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free CTKB Stock Alerts $6.26 -0.12 (-1.88%) (As of 02:03 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCytek Biosciences (CTKB) to Release Quarterly Earnings on Wednesdaymarketbeat.com - May 1 at 9:19 AMCytek Biosciences, Inc. (CTKB) Stock Moves -0.33%: What You Should Knowfinance.yahoo.com - April 30 at 9:49 PMCytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europeglobenewswire.com - April 30 at 5:30 PMCytek Biosciences (NASDAQ:CTKB) Trading 6.6% Higher marketbeat.com - April 29 at 2:32 PMCytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024globenewswire.com - April 29 at 9:00 AMNew York State Common Retirement Fund Grows Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB)marketbeat.com - April 27 at 6:33 AMMing Yan Sells 20,000 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) Stockinsidertrades.com - April 24 at 4:50 AMInsider Selling: Cytek Biosciences, Inc. (NASDAQ:CTKB) CTO Sells 20,000 Shares of Stockmarketbeat.com - April 23 at 9:13 PMShort Interest in Cytek Biosciences, Inc. (NASDAQ:CTKB) Increases By 16.9%marketbeat.com - April 14 at 7:21 PMMing Yan Sells 1,900 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) Stockinsidertrades.com - April 13 at 6:28 AMCytek Biosciences, Inc. (NASDAQ:CTKB) CTO Sells $13,300.00 in Stockmarketbeat.com - April 11 at 9:12 PMCytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Vanguard Group Inc.marketbeat.com - April 8 at 4:09 AMCytek Biosciences (NASDAQ:CTKB) Trading 5% Higher marketbeat.com - April 4 at 3:08 PMShort Interest in Cytek Biosciences, Inc. (NASDAQ:CTKB) Rises By 9.2%marketbeat.com - April 2 at 11:56 PMCTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023investorplace.com - March 27 at 12:05 PMCytek Biosciences (NASDAQ:CTKB) Stock Price Down 3.3%marketbeat.com - March 26 at 4:22 PMOptimistic Outlook: Cytek Biosciences Poised for Growth with New CFO Appointmentmarkets.businessinsider.com - March 21 at 10:55 PMCytek Biosciences (NASDAQ:CTKB) Shares Down 4.8% After Insider Sellingmarketbeat.com - March 20 at 11:34 AMInsider Sell: Cytek Biosciences Inc's (CTKB) Chief Technology Officer Ming Yan Sells 40,000 Sharesfinance.yahoo.com - March 20 at 11:01 AMCytek Biosciences, Inc. (NASDAQ:CTKB) CTO Ming Yan Sells 20,000 Sharesinsidertrades.com - March 20 at 6:52 AMCytek Biosciences, Inc. (NASDAQ:CTKB) CTO Sells $135,400.00 in Stockmarketbeat.com - March 19 at 8:14 PMCytek Biosciences Names William McCombe To Succeed Patrik Jeanmonod As CFO; Reaffirms 2024 Outlookmarkets.businessinsider.com - March 19 at 10:13 AMCytek® Biosciences Names William McCombe Chief Financial Officerglobenewswire.com - March 19 at 8:00 AMCTKB Mar 2024 5.000 putfinance.yahoo.com - March 15 at 8:31 AMCytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutionsglobenewswire.com - March 7 at 5:30 PMCytek Biosciences, Inc.: Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlookfinanznachrichten.de - March 7 at 4:43 AMPiper Sandler Reaffirms Their Buy Rating on Cytek Biosciences (CTKB)markets.businessinsider.com - March 6 at 10:18 PMRA Capital Management L.P. Reduces Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB)marketbeat.com - March 6 at 2:35 PMPiper Sandler Cuts Cytek Biosciences (NASDAQ:CTKB) Price Target to $10.00marketbeat.com - March 6 at 9:45 AMCytek Biosciences (NASDAQ:CTKB) Shares Gap Up Following Analyst Upgrademarketbeat.com - March 3 at 1:03 AMConnor Clark & Lunn Investment Management Ltd. Takes $1.26 Million Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)marketbeat.com - March 2 at 6:17 AMCytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 1 at 5:01 PMCytek Biosciences earnings matched, revenue topped estimatesinvesting.com - March 1 at 5:01 PMCytek Biosciences Reports Full Year 2023 Earningsfinance.yahoo.com - March 1 at 5:01 PMCytek Biosciences (NASDAQ:CTKB) Shares Gap Up After Analyst Upgrademarketbeat.com - March 1 at 10:15 AMCytek Biosciences Inc (CTKB) Reports Robust Revenue Growth and Positive Net Income in Q4 2023finance.yahoo.com - March 1 at 7:00 AMCytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 29 at 10:33 AMCytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlookglobenewswire.com - February 28 at 5:05 PMCytek Biosciences (NASDAQ:CTKB) Shares Gap Down to $8.64marketbeat.com - February 13 at 12:35 PMAfter losing 27% in the past year, Cytek Biosciences, Inc. (NASDAQ:CTKB) institutional owners must be relieved by the recent gainfinance.yahoo.com - February 13 at 9:55 AMCytek Biosciences, Inc. (NASDAQ:CTKB) Stake Boosted by Principal Financial Group Inc.marketbeat.com - February 9 at 4:36 AMNew York State Common Retirement Fund Has $12.96 Million Position in Cytek Biosciences, Inc. (NASDAQ:CTKB)marketbeat.com - February 7 at 5:46 AMCytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveriesfinance.yahoo.com - January 17 at 8:20 PMCytek Biosciences Announces Preliminary Full Year 2023 Revenue Resultsfinance.yahoo.com - January 8 at 1:02 PMCytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - December 28 at 7:21 PMPatrik Jeanmonod Sells 3,000 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) Stockmarketbeat.com - December 27 at 7:24 PMInsider Sell: Cytek Biosciences Inc's CTO Ming Yan Disposes of 20,000 Sharesfinance.yahoo.com - December 22 at 1:33 PMPiper Sandler Keeps Their Buy Rating on Cytek Biosciences (CTKB)markets.businessinsider.com - December 19 at 1:34 AMCytek Biosciences, Inc. (NASDAQ:CTKB) Sees Large Decrease in Short Interestmarketbeat.com - December 18 at 7:54 AMCytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Saysmarkets.businessinsider.com - December 14 at 3:52 PM Get Cytek Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CTKB and its competitors with MarketBeat's FREE daily newsletter. Email Address The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results. Don't miss out on the "next Ozempic" >>> CTKB Media Mentions By Week CTKB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTKB News Sentiment▼0.000.38▲Average Medical News Sentiment CTKB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTKB Articles This Week▼02▲CTKB Articles Average Week Get Cytek Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CTKB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Standard BioTools News EyePoint Pharmaceuticals News Quanterix News Valneva News Prothena News Allogene Therapeutics News Pacific Biosciences of California News Nautilus Biotechnology News Myriad Genetics News Olink Holding AB (publ) News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTKB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytek Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
